维普期刊资源整合服务平台（V6.5）

39篇 您的检索式：作者名="Bleumer I"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Immunogenecity of G250 peptides:rationale for a dendritic cell peptide vaccine trial in patients with advanced renal cell carcinoma显示文摘	Bleumer I Tiemessen D Oosterwijk-Wakka J	2002	Eur Urol Suppl2002，1，1：	1
2	Immunotherapy for renal cell carcinoma显示文摘	Bleumer I Oosterwi J K De Mulder P	2003	Eur Urol2003，44，：	1
3	A phaseⅡtrial of chi-meric monoclonal antibody G250 for advanced renal cell carcinomapatients显示文摘	Bleumer I Knuth A Oosterwijk E	2004	Br J Cancer2004，90，5：	1
4	Immunotherapy for renal cell carcinoma显示文摘	Bleumer I Ooserwijk E De Mulder P	2003	Eur Urol2003，44，1：	1
5	A clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin--2 pulsing scheme for advanced renal cell carcinoma显示文摘	Bleumer I Oosterwijk E Oosterwijk-Wakka JO et aI	2006	J Urol2006，175，1：	1
6	A phase II trial of chimeric mono-clonal antibody G250 for advanced renal cell carcinoma patient 显示文摘	Bleumer I Knuth A Oosterijk E	2004	Br J Cancer2004，90，5：	1
7	Immunotherapy for renal cell carcinoma显示文摘	Bleumer I Oosterwijk E De Mulder P	2003	EurUrol2003，44，1：	1
8	Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 study显示文摘	Oosterwijk-Wakka JC Tiemessen DM Bleumer I	2002	Immunity2002，25，：	1
9	A clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin-2 pulsing scheme for advanced renal cell carcinoma显示文摘	Bleumer I Oosterwijk-Wakka JC	2006	J Urol2006，175，1：	1
10	A phase Ⅱ trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients显示文摘	Bleumer I Knuth A Oosterwijk E	2004	Br J Cancer2004，90，：	1
11	Immunotherapy for renal cell carcinoma显示文摘	Bleumer I Ooserwijk E De Mulder P	2003	Eur Urol2003，44，1：	1
12	A clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin-2 pulsing scheme for advanced renal cell carcinoma 显示文摘	Bleumer I Oosterwijk E Oosterwijk-Wakka JC	2006	Urology2006，1，175：	1
13	A phase Ⅱ trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients显示文摘	Bleumer I Knuth A Oosterwijk E	2004	Br J Cancer2004，90，：	1
14	Preliminary analysis of patients with progressive renal cell carci-noma vaccinated with CA9 - peptide- pulsed mature dendritic cells显示文摘	BLEUMER I TIEMESSEN DM (X)STERWUK-WAKKA JC etal	2007	J Immunother2007，30，1：	1
15	Preliminary analysis of patients with progressive renal cell carcinoma vac-cinated with CA9-peptide-pulsed mature dendritic cells 显示文摘	Bleumer I Tiemessen D M Oosterwijk-Wakka J C	2007	J Immunother2007，30，1：	1
16	A clinical trial with chimericmonoclonal antibody WX-G250 and low dose intrleu-kin-2 pulsing scheme for advanced renal cell carcinoma显示文摘	Bleumer I Oosterwijk E Wakka J C		0，，01：	1
17	A clinical trial with chimeric monoelonal antibody WX-G250 and low dose interleakin-2 pulsing scheme for advanced renal cell carcinoma显示文摘	Bleumer I Oosterwijk-Wakka JC	2006	Urology2006，175，1：	1
18	A phase Ⅱ trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients 显示文摘	Bleumer I Knuth A Oosterwijk E	2004	Br J Cancer2004，90，：	1
19	Vaccina- tion of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combina- tion with interleukin-2: A phase 1 study 显示文摘	Oosterwijk-Wakka JC Tiemessen DM Bleumer I	2002	J Immunother2002，25，6：	1
20	A clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin--2 pulsing scheme for advanced renal cell carcinoma显示文摘	Bleumer I Oosterwijk E Oosterwijk-Wakka JC	2006	J Urol2006，175，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示